AYUVIS
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New Molecular Entities (NME)/ New Technologies as immune-modulating, anti-infective, and anti-inflammatory drugs. It is developing proprietary small molecule therapeutics, which have the potential to transform the treatment prospects for patients with life-threatening respiratory conditions including bronchopulmonary dysplasia, Pseudomonas aeruginosa pneumonia, cystic fibrosis, ARDS, COPD, and other inflammatory or infectious diseases. Suchismita Acharya founded the biotech company in 2014 and is based in Fort Worth, Texas.
AYUVIS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical Wellness
Founded:
2014-01-01
Address:
Fort Worth, Texas, United States
Country:
United States
Website Url:
http://www.ayuvis.com
Total Employee:
1+
Status:
Active
Contact:
(817) 554-8148
Email Addresses:
[email protected]
Total Funding:
3.9 M USD
Technology used in webpage:
Euro Google Google Cloud Wix
Similar Organizations
AutoImmune
AutoImmune is a biopharmaceutical company that develops products to treat autoimmune and other cell-mediated inflammatory conditions.
Jenrin Discovery
Jenrin Discovery is a biopharmaceutical Company.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Palo Santo Fund
Palo Santo Fund is an investment fund that invests in psychedelic and healthcare industry.
Current Advisors List
Current Employees Featured
Founder
Investors List
National Heart, Lung and Blood Institute
National Heart, Lung and Blood Institute investment in Grant - AyuVis
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) investment in Grant - AyuVis
Official Site Inspections
http://www.ayuvis.com Semrush global rank: 15.84 M Semrush visits lastest month: 1
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.171
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "AyuVis"
AyuVis - Crunchbase Company Profile & Funding
AyuVis is a start-up biopharmaceutical company, developing a new class of immunotherapies to prevent and treat inflammation and infection. Its focus is on the development of the New …See details»
Management Team | AyuVis Research Inc
Prior to AyuVis, she spent 12 years in leadership roles with Alcon Labs/Novartis and led R&D projects in ophthalmology. She is an innovative scientist, inventor of patents, and managed …See details»
Team | AyuVis Research Inc
AyuVis team members share the company’s focus and ambitious goals for addressing unmet clinical needs and finding solutions to treat patients who suffer from inflammatory and infectious diseases. Scientific Advisers.See details»
Ayuvis Research, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Ayuvis Research, Inc. of Fort Worth, TX. Get the latest business insights from Dun & Bradstreet.See details»
AyuVis Company Profile 2024: Valuation, Funding & Investors
AyuVis has raised $2.43M. Who are AyuVis’s investors? Ignite Healthcare Network , National Heart, Lung, and Blood Institute, MassChallenge , Eunice Kennedy Shriver National Institute …See details»
AyuVis Research, Inc. - Drug pipelines, Patents, Clinical trials
Explore AyuVis Research, Inc. with its drug pipeline, therapeutic area, technology platform, 6 literature, Disease Domain:Infectious Diseases, Technology Platform:Small molecule drug, …See details»
AyuVis Research | Seed - National Institutes of Health
The FDA granted AyuVis Orphan Drug and Rare Pediatric Disease Designations for AVR-48 to prevent BPD in at-risk preterm infants. The company has completed safety, efficacy testing, …See details»
AyuVis Research - VentureRadar
" AyuVis Research, Inc. is a preclinical stage pharmaceutical company focused on the discovery and development of novel multi functional small molecules which boost the body’s natural …See details»
AyuVis Research (Pharmaceuticals - United States) - Competitors ...
AyuVis Research is a pioneering company in the Pharmaceuticals and Biotechnology sector, focused on developing innovative treatments for complex respiratory conditions such as …See details»
AyuVis - Contacts, Employees, Board Members, Advisors & Alumni …
Organization. AyuVis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... About. AyuVis has 7 current employee profiles, …See details»
Management Team | AyuVis Research Inc
Prior to AyuVis, She spent 15 years in various leadership roles with Alcon Labs (Novartis) and led projects from early stage to pre-clinical in glaucoma, AMD and anti-viral diseases. She is an …See details»
AyuVis Research - Facebook
AyuVis Research. 110 likes. AyuVis is developing a new, third generation of immunotherapies, small molecule drugs that work through the innate immune system, to treat both acute and …See details»
AyuVis - Ignite Health
AyuVis is pioneering the design, synthesis and development of novel small molecules to prevent and treat inflammatory and infectious diseases via recharging the innate immune system for a …See details»
Listen: This Fort Worth health startup is trying to put your immune ...
Apr 6, 2022 In the latest installment of our occasional conversations with Fort Worth leaders, Suchismita Acharya, the founder and CEO of AyuVis, discusses the importance of …See details»
Startup AyuVis’ First Patent Granted in U.S., 3 Other Countries
The patent also has been approved by Canada, South Korea and Australia, and is under examination in the European Patent Organization, Brazil, Japan, China/Hong Kong and …See details»
AyuVis receives FDA Fast Track for drug preventing preterm infant …
Oct 15, 2024 Congrats to Dr. Suchismita Acharya, founder and CEO of AyuVis and assistant professor of Pharmacology and Neuroscience at CBTS. AyuVis Research Inc., a clinical-stage …See details»
AyuVis awarded $2.1 million NIH grant to support clinical trial
May 17, 2023 It is the fourth NIH grant AyuVis has received since its founding, doubling total non-dilutive funding to $4.2M. The NHLBI is the third largest institute of the NIH in the U.S. …See details»
Research | AyuVis Research Inc
AyuVis began its drug discovery program by designing small molecule analogs of chitohexaose that would preserve its beneficial therapeutic properties and safety profile but be optimized for …See details»
AyuVis Granted FDA Approval for Human Trials of ... - Bio North …
Jan 25, 2024 AyuVis Research, Inc., a clinical-stage biopharmaceutical company focusing on immunotherapies for inflammation and infection, has received FDA approval to commence …See details»